Presentation THT 2022 Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF Presenter: Scott Solomon February 01, 2022 REGISTER for free or LOG IN to view this content Heart Failure THT 2022 Heart Failure Up Next Presentation THT 2022 Changes in Voice Patterns for Monitoring Volume Status (Cardio) Presenter: Chaim Lotan February 01, 2022 More slides + Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022 Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022 We Recommend Disclosures NULL
Presentation THT 2022 Changes in Voice Patterns for Monitoring Volume Status (Cardio) Presenter: Chaim Lotan February 01, 2022
Presentation THT 2022 Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease Presenter: Barry Greenberg February 01, 2022
Presentation THT 2022 PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts! Presenter: Roham Zamanian February 01, 2022